Nigeria, April 29 -- Fidson Healthcare turned in 213.5 per cent more in profit in the first quarter of the year, compared to the same period of 2025, its financial report showed on Monday, as Nigeria's fast-growing market for prescription drugs boosted sales.

Ethical drugs, alternatively called prescription medicine, grew by N10.8 billion, alone accounting for 65.6 per cent of revenue. Turnover was up by 85.4 per cent at N35 billion, just a fraction of it contributed by exports.

The outlook for the Nigerian prescription drug market is projected to be bullish in the years ahead, with Statista forecasting revenue to reach $2.9 billion in 2025 and an annual growth rate of 3.6 per cent this year through 2029. An expanding middle class and h...